Drug-Target Interaction Prediction By Combining Transformer and Graph Neural Networks

IF 2.4 3区 生物学 Q3 BIOCHEMICAL RESEARCH METHODS
Junkai Liu, Yaoyao Lu, Shixuan Guan, Tengsheng Jiang, Yijie Ding, Qiming Fu, Zhiming Cui, Hongjie Wu
{"title":"Drug-Target Interaction Prediction By Combining Transformer and Graph Neural Networks","authors":"Junkai Liu, Yaoyao Lu, Shixuan Guan, Tengsheng Jiang, Yijie Ding, Qiming Fu, Zhiming Cui, Hongjie Wu","doi":"10.2174/1574893618666230912141426","DOIUrl":null,"url":null,"abstract":"Background: The prediction of drug-target interactions (DTIs) plays an essential role in drug discovery. Recently, deep learning methods have been widely applied in DTI prediction. However, most of the existing research does not fully utilize the molecular structures of drug compounds and the sequence structures of proteins, which makes these models unable to obtain precise and effective feature representations. Methods: In this study, we propose a novel deep learning framework combining transformer and graph neural networks for predicting DTIs. Our model utilizes graph convolutional neural networks to capture the global and local structure information of drugs, and convolutional neural networks are employed to capture the sequence feature of targets. In addition, the obtained drug and protein representations are input to multi-layer transformer encoders, respectively, to integrate their features and generate final representations. Results: The experiments on benchmark datasets demonstrated that our model outperforms previous graph-based and transformer-based methods, with 1.5% and 1.8% improvement in precision and 0.2% and 1.0% improvement in recall, respectively. The results indicate that the transformer encoders effectively extract feature information of both drug compounds and proteins. Conclusion: Overall, our proposed method validates the applicability of combining graph neural networks and transformer architecture in drug discovery, and due to the attention mechanisms, it can extract deep structure feature data of drugs and proteins.","PeriodicalId":10801,"journal":{"name":"Current Bioinformatics","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2023-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Bioinformatics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1574893618666230912141426","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The prediction of drug-target interactions (DTIs) plays an essential role in drug discovery. Recently, deep learning methods have been widely applied in DTI prediction. However, most of the existing research does not fully utilize the molecular structures of drug compounds and the sequence structures of proteins, which makes these models unable to obtain precise and effective feature representations. Methods: In this study, we propose a novel deep learning framework combining transformer and graph neural networks for predicting DTIs. Our model utilizes graph convolutional neural networks to capture the global and local structure information of drugs, and convolutional neural networks are employed to capture the sequence feature of targets. In addition, the obtained drug and protein representations are input to multi-layer transformer encoders, respectively, to integrate their features and generate final representations. Results: The experiments on benchmark datasets demonstrated that our model outperforms previous graph-based and transformer-based methods, with 1.5% and 1.8% improvement in precision and 0.2% and 1.0% improvement in recall, respectively. The results indicate that the transformer encoders effectively extract feature information of both drug compounds and proteins. Conclusion: Overall, our proposed method validates the applicability of combining graph neural networks and transformer architecture in drug discovery, and due to the attention mechanisms, it can extract deep structure feature data of drugs and proteins.
结合变形神经网络和图神经网络的药物-靶标相互作用预测
背景:药物-靶标相互作用(DTIs)预测在药物发现中起着至关重要的作用。近年来,深度学习方法在DTI预测中得到了广泛应用。然而,现有的研究大多没有充分利用药物化合物的分子结构和蛋白质的序列结构,使得这些模型无法获得精确有效的特征表示。方法:在本研究中,我们提出了一种结合变压器和图神经网络的新型深度学习框架来预测dti。我们的模型利用图卷积神经网络捕获药物的全局和局部结构信息,并利用卷积神经网络捕获靶点的序列特征。此外,将获得的药物表征和蛋白质表征分别输入到多层变压器编码器中,进行特征整合并生成最终表征。结果:在基准数据集上的实验表明,我们的模型优于先前基于图和变压器的方法,精度分别提高1.5%和1.8%,召回率分别提高0.2%和1.0%。结果表明,变压器编码器可以有效地提取药物化合物和蛋白质的特征信息。结论:总的来说,我们提出的方法验证了图神经网络和变压器架构相结合在药物发现中的适用性,并且由于注意机制,可以提取药物和蛋白质的深层结构特征数据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Bioinformatics
Current Bioinformatics 生物-生化研究方法
CiteScore
6.60
自引率
2.50%
发文量
77
审稿时长
>12 weeks
期刊介绍: Current Bioinformatics aims to publish all the latest and outstanding developments in bioinformatics. Each issue contains a series of timely, in-depth/mini-reviews, research papers and guest edited thematic issues written by leaders in the field, covering a wide range of the integration of biology with computer and information science. The journal focuses on advances in computational molecular/structural biology, encompassing areas such as computing in biomedicine and genomics, computational proteomics and systems biology, and metabolic pathway engineering. Developments in these fields have direct implications on key issues related to health care, medicine, genetic disorders, development of agricultural products, renewable energy, environmental protection, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信